Diagnostic News and Research

RSS

Autism diagnosis test is less reliable than previously assumed, study finds

Rutgers researchers have found that a test widely used to diagnose whether children have autism is less reliable than previously assumed.

27 Jan 2020

Weak evidence found on added benefit of asfotase alfa treatment for infants with hypophosphatasia

Hypophosphatasia (HPP) is a rare congenital metabolic disorder. The frequency of severe courses of disease is estimated at 1:100 000: A deficiency of the enzyme phosphatase results in insufficient mineralization of the bones and thus in severe skeletal malformations.

27 Jan 2020

Expert genomics panel disputes certain genes linked to a dangerous heart condition

A panel of experts have said that nine genes linked to a dangerous heart disorder called long QT syndrome, are not associated with the condition.

27 Jan 2020

ClinGen expert panel disputes nine genes linked to long QT syndrome

Geneticists and heart specialists around the world had previously reported 17 genes to cause long QT syndrome, a little-known inherited heart condition. However, the Clinical Genome Resource's expert panel has critically reevaluated the scientific evidence for all 17 reported genes, disputing nine of the genes and revealing only three of the genes to be definitively associated with the most common form of the disease.

27 Jan 2020

Noscendo and UKB partner to expand DISQVER platform in the field of microbial resistances

Noscendo GmbH and the University Hospital Bonn today announced the successful signing of a cooperative agreement with the Institute for Hygiene and Public Health at the UKB, working towards expansion of the proprietary and CE-certified diagnostic platform DISQVER in the field of microbial resistances.

27 Jan 2020

Determining Microsatellite Instability Status Using Multiplex PCR-Based Methods

Determining microsatellite instability status using multiplex PCR-based methods used to screen for Lynch Syndrome, a dominant hereditary cancer propensity.

From Promega Corporation 24 Jan 2020

CRNAs offer safe, affordable solution for care as rural hospitals continue to close

As the 2020 presidential candidates propose to fix U.S. healthcare, rural hospitals across the country continue to close. Since the 2018 midterms, about 66 percent of primary care physician shortages have been in rural and partially rural areas.

24 Jan 2020

Developing diagnostic tools based on science of the sniff

As the medical industry continues its quest for accurate and reliable diagnostic tools, more is becoming understood about the science of the sniff.

24 Jan 2020

Meridian launches High-Specificity Pfu HS Mix to increase customers’ testing capabilities

Meridian Bioscience, Inc. today announced the launch of a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification, but also offers market-leading amplification for companion diagnostic (CDx) and clinical testing.

From Meridian Bioscience, Inc. 24 Jan 2020

NIAID officials describe steps to control coronavirus that recently originated in China

The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family of coronaviruses (CoVs) has jumped from animals to humans and sparked an outbreak.

24 Jan 2020

RNAssist and Rapid Labs agree on a manufacturing and supply agreement for genoPHIX and vivoPHIX

RNAssist has developed several universal biological sample stabilization, fixation and microbial inactivation reagents.

From Rapid Labs Ltd 23 Jan 2020

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for positron emission tomography (PET) probe F-18 NKO-035, a LAT1-selective amino acid derivative radiolabeled with 18F, confirming its safety in first-in-human clinical studies conducted at Osaka University Hospital in November 2019.

22 Jan 2020

Decline in advanced stage cancer diagnoses following health insurance expansion

Advanced stage cancer diagnoses declined following health insurance expansion in Massachusetts, likely due to increased access to screening and diagnostic services that identified cancers earlier, according to new research led by health economists at the University of Pittsburgh Graduate School of Public Health.

22 Jan 2020

Diagnostic News and Research

Autism diagnosis test is less reliable than previously assumed, study finds

Weak evidence found on added benefit of asfotase alfa treatment for infants with hypophosphatasia

Expert genomics panel disputes certain genes linked to a dangerous heart condition

ClinGen expert panel disputes nine genes linked to long QT syndrome

Noscendo and UKB partner to expand DISQVER platform in the field of microbial resistances

Determining Microsatellite Instability Status Using Multiplex PCR-Based Methods

CRNAs offer safe, affordable solution for care as rural hospitals continue to close

Developing diagnostic tools based on science of the sniff

Meridian launches High-Specificity Pfu HS Mix to increase customers’ testing capabilities

NIAID officials describe steps to control coronavirus that recently originated in China

RNAssist and Rapid Labs agree on a manufacturing and supply agreement for genoPHIX and vivoPHIX

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

Decline in advanced stage cancer diagnoses following health insurance expansion

Exosomics SpA implements NanoFCM’s NanoAnalyzer to offer wider range of services

Raman spectroscopy can be used to diagnose the state of thrombocytes in cardiovascular patients

Prolonged breath-holding could have potential as part of new treatment for cardiac arrhythmias

Researchers discover new regions of non-coding DNA that may lead to cancer growth

Researchers develop novel assay to detect Chinese coronavirus

Greater medical care needed for older adults with untreated sleep apnea

New method for detection of microcystins and nodularin in human urine

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News